Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma

Canadian Journal of Gastroenterology

Volumn 25, Issue 11, 2011, Pages 603-608

  Jiang, Bei Ge ^a   Ge, Rui Liang ^a   Sun, Liang Liang ^b   Zong, Ming ^a   Wei, Gong Tian ^a   Zhang, Yong Jie ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Intrahepatic cholangiocarcinoma; Mathematical model; Prognosis; Survival duration prediction

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEPATITIS B; HUMAN; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

EID: 81055123644     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/917097     Document Type: Article

References (25)

1. de Groen PC, Gores GJ, Larusso NF, et al. Biliary tract cancers. N Engl J Med 1999;341:1368-78.
2. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-25. (Pubitemid 38738341)
3. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002;2:10.
4. Khan SA, Taylor-Robinson SD, Toledano MB, et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002;37:806-13. (Pubitemid 35404220)
5. Lang H, Sotiropoulos GC, Fruhauf NR, et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): When is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 2005;241:134-43. (Pubitemid 40041002)
6. Akatsu T, Shimazu M, Kawachi S, et al. Long-term survival of intrahepatic cholangiocarcinoma with hilar lymph node metastasis and portal vein involvement. Hepatogastroenterology 2005;52:603-5. (Pubitemid 40469476)
7. Asakura H, Ohtsuka M, Ito H, et al. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology 2005;52:722-4. (Pubitemid 40834591)
8. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 2002;183:679-85. (Pubitemid 34722537)
9. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525-31. (Pubitemid 35404319)
10. Nakagohri T, Asano T, Kinoshita H, et al. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg 2003;27:289-93. (Pubitemid 36920139)
11. Suzuki S, Sakaguchi T, Yokoi Y, et al. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 2002;26:687-93. (Pubitemid 36920344)
12. Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: Resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001;193:384-91. (Pubitemid 32895979)
13. Uenishi T, Hirohashi K, Kubo S, et al. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma. Hepatogastroenterology 2003;50:1069-72. (Pubitemid 36723845)
14. Shimada M, Yamashita Y, Aishima S, et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 2001;88:1463-6. (Pubitemid 32989464)
15. Isaji S, Kawarada Y, Taoka H, et al. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999;6:108-16.
16. Jan YY, Yeh CN, Yeh TS, et al. Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma. World J Surg 2005;29:894-8.
17. Nakagawa T, Kamiyama T, Kurauchi N, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005;29:728-33. (Pubitemid 41187533)
18. Jiang BG, Sun LL, Yu WL, et al. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma. Cancer J 2009;15:257-61.
19. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: Rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008;248:84-96.
20. Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009;16:14-22.
21. Paik KY, Jung JC, Heo JS, et al. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 2008;23:766-70. (Pubitemid 351519418)
22. Inoue K, Makuuchi M, Takayama T, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000;127:498-505. (Pubitemid 30257507)
23. Yamamoto M, Takasaki K, Imaizumi T, et al. A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: A case report. Jpn J Clin Oncol 2002;32:206-9. (Pubitemid 41288998)
24. Uenishi T, Yamazaki O, Horii K, et al. A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis. J Gastroenterol 2006;41:391-2. (Pubitemid 43834386)
25. Okami J, Dohno K, Sakon M, et al. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. Clin Cancer Res 2000;6:2326-32. (Pubitemid 30399199)